Literature DB >> 31903228

Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience.

Michael MacManus1,2, Richard De Abreu Lourenco3, Fiona Hegi-Johnson1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31903228      PMCID： PMC6940268          DOI： 10.21037/jtd.2019.10.13

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

1.  A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer.

Authors:  Gregory M M Videtic; Chandana A Reddy; Lisa Sorenson
Journal:  Support Care Cancer       Date:  2012-06-02       Impact factor: 3.603

2.  Surgery versus SABR for resectable non-small-cell lung cancer.

Authors:  Masatsugu Hamaji; Shawn S Groth; David J Sugarbaker; Bryan M Burt
Journal:  Lancet Oncol       Date:  2015-08       Impact factor: 41.316

3.  A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question?

Authors:  Carsten Nieder; Nicolaus H Andratschke; Matthias Guckenberger
Journal:  Ann Transl Med       Date:  2015-07

4.  Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life.

Authors:  Gregory M M Videtic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-12-01       Impact factor: 7.038

5.  Quality of life and symptoms following stereotactic body radiotherapy in early-stage lung cancer patients.

Authors:  Virginia Sun; Jae Y Kim; Anna Cathy Williams; Dan J Raz; Sagus Sampath; Betty Ferrell
Journal:  J Community Support Oncol       Date:  2014-11

6.  Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer.

Authors:  Frank J Lagerwaard; Neil K Aaronson; Chad M Gundy; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  J Thorac Oncol       Date:  2012-07       Impact factor: 15.609

7.  Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.

Authors:  Joshua E Rosen; Michelle C Salazar; Zuoheng Wang; James B Yu; Roy H Decker; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa
Journal:  J Thorac Cardiovasc Surg       Date:  2016-04-07       Impact factor: 5.209

8.  Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Noëlle C van der Voort van Zyp; Jean-Briac Prévost; Bronno van der Holt; Cora Braat; Robertus J van Klaveren; Peter M Pattynama; Peter C Levendag; Joost J Nuyttens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-26       Impact factor: 7.038

Review 9.  Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review.

Authors:  Hermine Poghosyan; Lisa Kennedy Sheldon; Suzanne G Leveille; Mary E Cooley
Journal:  Lung Cancer       Date:  2013-04-04       Impact factor: 5.705

10.  Surgery versus SABR for resectable non-small-cell lung cancer.

Authors:  Charles Dearman; Nicholas van As; Adrian Crellin; Nicholas Slevin; Ricky A Sharma
Journal:  Lancet Oncol       Date:  2015-08       Impact factor: 41.316
View more
  1 in total

1.  Applied research of a four-dimensional CT localization technique in radiotherapy and treatment planning for early lung cancer.

Authors:  Gang Wang; Xiwen Zhu; Fan Zhang; Jing Liu; Lu Yue; Lihua Deng; Mi Zhou
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.